巯嘌呤甲基转移酶遗传多态性对硫唑嘌呤药动学和药效学影响的研究概况
The Influence of Thiopurine Methyltransferase Polymorphism on Pharmacokinetics and Pharmacodynamics of Azathioprine
摘要
目的总结近年来巯嘌呤甲基转移酶(thiopurine methyltransferase,TPMT)遗传多态性对硫唑嘌呤药动学和药效学影响的研究概况。方法查阅近年来国内外有关文献资料,进行分析、整理和归纳。结果TPMT是硫唑嘌呤代谢过程中的重要代谢酶,TPMT活性和硫唑嘌呤活性代谢物———6-鸟嘌呤核苷酸稳态浓度成负相关;TPMT遗传多态性与硫唑嘌呤的治疗效果及毒副作用密切相关。结论TPMT活性测定和基因型分析具有潜在的临床应用价值;除TPMT缺陷外,临床用药过程中应关注导致骨髓抑制的其他因素,如药物相互作用、药物或病原体引起的骨髓抑制等。
出处
《中国药学杂志》
CAS
CSCD
北大核心
2006年第11期801-803,共3页
Chinese Pharmaceutical Journal
参考文献28
-
1BERGAN S,RUGSTAD H E,KLEMETSDAL B,et al.Possibilities for therapeutic drug monitoring of azathioprine:6-thioguanine nucleotide concentrations and thiopurine methyltransferase activity an red blood cells[J].Ther Drug Monit,1997,19:318-326.
-
2COLLIE-DUGUID E S R,PRITCHARD S C,POWRIE R H,et al.The frequency and distribution of thiopurine methyltransferase alleles in caucasian and asian populations[J].Pharmacogenetics,1999,9:37-42.
-
3HOLME S A,DULEY J A,SANDERSON J,et al.Erythrocyte thiopurine methyltransferase assement prior to azathioprine use in UK[J].Q J Med,2002,95:439-444.
-
4COROMINAS H,BAIGET M.Clinical utility of thiopurine S-methyltransferase genotyping[J].Am J Pharmacogenomics,2004,4(1):1-8.
-
5SCHMITZ G,ASLANIDIS C,LACKNER K J.Pharmacogenomics:implication for laboratory medicine[J].Clin Chim Acta,2001,308:43-53.
-
6EVANS W E.Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy[J].Ther Drug Monit,2004,26(2):186-191.
-
7FORMEA C M,MYERS-HUENTELMAN H,WU R,et al.Thiopurine S-methyltransferase genotype predicts azathioprine-induced myelotoxicity in kidney transplant recipients[J].Am J Transplant,2004,4(11):1810-1817.
-
8ESCOUSS A,GUEDON F,MOUNIE J,et al.6-Mercaptopurine pharmacokinetics after use of azathioprine in renal transplant recipients with intermediate or high thiopurine methyltransferase activity phenotype[J].J Pharm Pharmacol,1998,50:1261-1266.
-
9ESCOUSSE A,RIFLE G,SGRO C,et al.Azathioprine toxicity,6-mercaptopurine accumulation and the "poor" t-thiopurine methylator phenotype[J].Eur J Clin Pharmacol,1995,48:309-310.
-
10KUROWSKI V,IVEN H.Plasma concentrations and organ distribution of thiopurines after oral application of azathioprine in mice[J].Can Chemother Pharmacol,1991,28:7-14.
-
1张波,徐小薇,曾学军,李大魁.巯嘌呤甲基转移酶活性对硫唑嘌呤中间代谢物6-巯基嘌呤药动学的影响[J].中国药学杂志,2006,41(14):1093-1096. 被引量:6
-
2张波,徐小薇,付强,李大魁.人红细胞中巯嘌呤甲基转移酶活性的HPLC测定法[J].中国药学杂志,2004,39(12):941-943. 被引量:7
-
3谢偲,岳丽杰.巯嘌呤甲基转移酶基因多态性与巯嘌呤类药物治疗关系的研究进展[J].中国临床药理学杂志,2013,29(11):865-868. 被引量:2
-
4葛健,夏瑞祥,杨明珍,夏海龙,王永庆,曾庆曙.巯嘌呤甲基转移酶基因多态性对成人急性淋巴细胞白血病6-MP治疗个体化的意义[J].安徽医科大学学报,2014,49(5):665-669. 被引量:3
-
5张波,徐小薇,曾学军,李大魁.北京地区汉族人巯嘌呤甲基转移酶活性分布状况和基因型分析[J].中国药学杂志,2005,40(22):1730-1733. 被引量:1
-
6熊晖,熊磊,苏丹,辛华雯,吴笑春,李罄,李高.HPLC法检测人红细胞中巯嘌呤甲基转移酶的活性[J].中国药师,2007,10(8):738-740. 被引量:4
-
7药物反应[J].中国医学文摘(皮肤科学),2011(4):237-238.
-
8夏泉,黄燕,汪燕燕,许杜娟,胡乃中,胡静,梅俏,陈飞虎.巯嘌呤甲基转移酶基因多态性联合硫鸟嘌呤核苷酸血药浓度监测在硫唑嘌呤治疗炎症性肠病治疗中的临床应用[J].中国临床药理学与治疗学,2014,19(3):302-308. 被引量:8
-
9温晓飞.西地那非与利钠肽对肾功能的作用[J].中国男科学杂志,2007,21(12):15-15.
-
10葛健,夏瑞祥,曾庆曙,金涌,过林,陈纭.高效液相色谱法测定急性淋巴细胞白血病患者巯嘌呤甲基转移酶活性[J].中国医院药学杂志,2006,26(5):520-522. 被引量:5